Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Anderson

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Blood|October 15, 2011
"Sowing dragon's teeth?" Myeloma and AMLPhilip L McCarthy, Kouros Owzar, Kenneth Anderson
Journal of Oncology Practice|March 9, 2018
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update SummaryKenneth Anderson, Nofisat Ismaila, Robert A Kyle
Journal of Strength and Conditioning Research|August 14, 2002
Muscle force and activation under stable and unstable conditionsDavid G Behm, Kenneth Anderson, Robert S Curnew
Cancer Research|November 13, 2003
A workshop on the marrow microenvironment and hematological malignancyYong Sung Choi, Kenneth Anderson, R Allan Mufson
The Journal of Physical Chemistry. A|April 14, 2017
Toward the Mechanism of Perchlorinated Cyclopentasilane (Si<sub>5</sub>Cl<sub>10</sub>) Ring Flattening in the [Si<sub>5</sub>Cl<sub>10</sub>·2Cl]<sup>2-</sup> DianionKonstantin Pokhodnya, Kenneth Anderson, Svetlana Kilina, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Maximizing the clinical benefit of novel therapies in multiple myelomaJacob Laubach, Constantine Mitsiades, Kenneth Anderson, et al.
Seminars in Oncology|October 19, 2013
Clinical translation in multiple myeloma: from bench to bedsideJacob Laubach, Teru Hideshima, Paul Richardson, et al.
Current Opinion in Oncology|September 22, 2006
Beyond single-agent bortezomib: combination regimens in relapsed multiple myelomaPaul G Richardson, Constantine Mitsiades, Irene Ghobrial, et al.
Annals of Medicine|July 1, 2004
Proteasome inhibition in hematologic malignanciesPaul G Richardson, Teru Hideshima, Constantine Mitsiades, et al.
The Oncologist|July 2, 2013
Cancer clinical trials--do we need a new algorithm in the age of stratified medicine?James H Doroshow, Stefan Sleijfer, Roger Stupp, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Blood|October 15, 2011
"Sowing dragon's teeth?" Myeloma and AMLPhilip L McCarthy, Kouros Owzar, Kenneth Anderson
Journal of Oncology Practice|March 9, 2018
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update SummaryKenneth Anderson, Nofisat Ismaila, Robert A Kyle
Journal of Strength and Conditioning Research|August 14, 2002
Muscle force and activation under stable and unstable conditionsDavid G Behm, Kenneth Anderson, Robert S Curnew
Cancer Research|November 13, 2003
A workshop on the marrow microenvironment and hematological malignancyYong Sung Choi, Kenneth Anderson, R Allan Mufson
The Journal of Physical Chemistry. A|April 14, 2017
Toward the Mechanism of Perchlorinated Cyclopentasilane (Si<sub>5</sub>Cl<sub>10</sub>) Ring Flattening in the [Si<sub>5</sub>Cl<sub>10</sub>·2Cl]<sup>2-</sup> DianionKonstantin Pokhodnya, Kenneth Anderson, Svetlana Kilina, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Maximizing the clinical benefit of novel therapies in multiple myelomaJacob Laubach, Constantine Mitsiades, Kenneth Anderson, et al.
Seminars in Oncology|October 19, 2013
Clinical translation in multiple myeloma: from bench to bedsideJacob Laubach, Teru Hideshima, Paul Richardson, et al.
Current Opinion in Oncology|September 22, 2006
Beyond single-agent bortezomib: combination regimens in relapsed multiple myelomaPaul G Richardson, Constantine Mitsiades, Irene Ghobrial, et al.
Annals of Medicine|July 1, 2004
Proteasome inhibition in hematologic malignanciesPaul G Richardson, Teru Hideshima, Constantine Mitsiades, et al.
The Oncologist|July 2, 2013
Cancer clinical trials--do we need a new algorithm in the age of stratified medicine?James H Doroshow, Stefan Sleijfer, Roger Stupp, et al.
Pageof 11